Skip to content

Drug interactions

Dasatinib + Ethinyl estradiol-norgestimate

Severity: Minor

Dasatinib and Ethinyl estradiol-norgestimate: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ethinyl estradiol is a weak CYP3A4 inhibitor and could raise dasatinib levels slightly. Dasatinib toxicity such as myelosuppression, fluid retention or QT prolongation could be increased. The clinical significance is probably small.

What this interaction means in plain words

Dasatinib and Ethinyl estradiol-norgestimate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dasatinib belongs to Oncology; Ethinyl estradiol-norgestimate belongs to Endocrine.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4-mediated dasatinib metabolism by ethinyl estradiol.

What to do

No routine dose change is needed; monitor blood counts and for fluid retention as part of normal dasatinib care. Note that dasatinib is teratogenic and contraception counseling should continue.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Ethinyl estradiol-norgestimate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Ethinyl estradiol-norgestimate?

MediHelp rates the interaction as minor. Dasatinib and Ethinyl estradiol-norgestimate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ethinyl estradiol is a weak CYP3A4 inhibitor and could raise dasatinib levels slightly. Dasatinib toxicity such as myelosuppression, fluid retention or QT prolongation could be increased. The clinical significance is probably small.

How serious is the interaction between Dasatinib and Ethinyl estradiol-norgestimate?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor blood counts and for fluid retention as part of normal dasatinib care. Note that dasatinib is teratogenic and contraception counseling should continue.

What other medicines interact with Ethinyl estradiol-norgestimate?

MediHelp also lists interactions of Ethinyl estradiol-norgestimate with, for example, Fezolinetant, Ombitasvir / paritaprevir / ritonavir and dasabuvir, Tranexamic acid. The full list is on the Ethinyl estradiol-norgestimate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in